<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31719014</article-id><article-id pub-id-type="pmc">6852441</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0329</article-id><article-categories><subj-group subj-group-type="heading"><subject>How I Do It</subject></subj-group></article-categories><title-group><article-title>The Russian Conduit - Combining Bentall and Ozaki Procedures for
Concomitant Ascending Aorta Replacement and Aortic Valve
Neocuspidization</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Komarov</surname><given-names>Roman</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Chernov</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Enginoev</surname><given-names>Soslan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5356-2996</contrib-id><name><surname>S&#x000e1;</surname><given-names>Michel Pompeu B. O.</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Tarasov</surname><given-names>Dmitry</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD, PhD, ChM</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Clinic of Aortic and Cardiovascular Surgery, Sechenov First Moscow
State Medical University of Health Ministry of Russia, Moscow, Russia.</aff><aff id="aff2">
<label>2</label>Department of Cardiac Surgery, Federal Center for Cardiovascular
Surgery, Russia</aff><aff id="aff3">
<label>3</label>Astrakhan State Medical University, Astrakhan, Russia.</aff><aff id="aff4">
<label>4</label>Division of Cardiovascular Surgery, Pronto-Socorro
Cardiol&#x000f3;gico de Pernambuco - Prof. Luiz Tavares, PROCAPE, Recife,
Brazil.</aff><aff id="aff5">
<label>5</label>University of Pernambuco, UPE, Recife, Brazil.</aff><aff id="aff6">
<label>6</label>Nucleus of Postgraduate and Research in Health Sciences of Faculty
of Medical Sciences and Biological Sciences Institute, FCM/ICB, Recife,
Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Michel Pompeu Barros Oliveira
S&#x000e1;</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-5356-2996">https://orcid.org/0000-0001-5356-2996</ext-link>, Division of
Cardiovascular Surgery, Pronto-Socorro Cardiol&#x000f3;gico de Pernambuco - Prof.
Luiz Tavares, PROCAPE, Rua dos Palmares, S/N - Santo Amaro, Pernambuco, Recife,
Brazil. Zip Code: 74970-240. E-mail:
<email>michel_pompeu@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>618</fpage><lpage>623</lpage><history><date date-type="received"><day>02</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>02</day><month>8</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>In aortic valve disease cases, prosthetic valves have been used for valve
replacement, however, these prostheses have inherent problems, and their quality
in some countries is lower comparing to new-generation models, causing shorter
durability. Aortic valve neocuspidization (AVNeo) has emerged as an option,
which can be applied to a wide spectrum of these diseases. Despite the promising
results, this procedure is not widely spread among cardiac surgeons yet. We
developed a surgical technique combining Bentall and Ozaki procedures to treat
patients with concomitant ascending aorta replacement and AVNeo and we describe
it in this paper.</p><p>
<fig id="f11" orientation="portrait" position="anchor"><caption><p>The Russian conduit &#x02013; combination of Bentall and Ozaki
procedures.</p></caption><graphic xlink:href="rbccv-34-05-0618-g11"/></fig>
</p></abstract><kwd-group><kwd>Heart Valve Diseases</kwd><kwd>Aortic Valve Diseases</kwd><kwd>Aorta, Replantation</kwd><kwd>Prostheses and Implants</kwd><kwd>Surgeons</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ascending aorta</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic valve</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AVA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic valve
annulus</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AVNeo</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic valve
neocuspidization</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DTG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Dacron tube graft</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TEE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Transesophageal
echocardiography</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Bentall-DeBono operation for aortic valve (AV) and ascending aorta (AA) replacement
with a valve-containing conduit, first performed in 1966, occupies a unique position
in the course of development of operations on the aorta. Currently, it is widely
used in cardiac surgery and it is considered as a &#x0201c;gold standard&#x0201d; for pathologies
affecting AA and AV<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. The advantages of this
approach are a proven methodology and high-quality long-term results. The well-known
problems associated with this surgical procedure include, among others,
complications due to the need to receive anticoagulants when patients choose
mechanical prostheses<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Moreover, the use of
artificial prostheses has always been associated with a residual pressure gradient,
whose severity strongly depends on its type and size and is explained by the
presence of a frame and a cuff for fixation, reducing the effective orifice area.
Additionally, there is the risk of postoperative infective endocarditis.
Bioprostheses, especially in young patients, are prone to structural valve
degeneration<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. The exact mechanism through which the fibrosis and/or
calcification develops remains undisclosed, being possible the existence of an
underlying role of an immune response against the bioprosthesis<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Ozaki et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>
developed a technique for AV cusps replacement, which are cut out according to the
original template and made of the patient&#x02019;s pericardium treated with glutaraldehyde.
It is fully logical that, with an aortic aneurysm and degeneratively altered AV
cusps, the most promising and most physiologically and surgically convenient
treatment option would be a combination of Bentall-DeBono operation with Dacron
prostheses and aortic valve neocuspidization (AVNeo) with autologous pericardium
(Ozaki procedure).</p><p>The objective of this paper is to describe the technique with the Russian conduit for
execution of the Bentall-Ozaki procedure, so that other surgeons could become
familiarized with this new approach in the treatment of patients with AA disease
(aneurysm or dissection) associated with AV disease.</p></sec><sec><title>TECHNIQUE NUMBER 1</title><sec><title>Step 1</title><p>Access to the heart through median sternotomy (<xref ref-type="fig" rid="f1">Figure 1A</xref>) and autologous pericardium harvesting (<xref ref-type="fig" rid="f1">Figure 1B</xref>) with further processing with 0.6%
glutaraldehyde for 8 minutes, then treatment twice for 8 minutes with saline
solution. Meanwhile, a transesophageal echocardiography (TEE) is performed in
order to measure the aortic valve annulus (AVA).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Step 1.</p></caption><graphic xlink:href="rbccv-34-05-0618-g01"/></fig>
</p></sec><sec><title>Step 2</title><p>The size of the Dacron tube graft (DTG) must be calculated (<xref ref-type="fig" rid="f2">Figure 2A</xref>). If AVA is not enlarged, then the size of the DTG
equals AVA plus 5 mm. If AVA is enlarged, then, 30 or 32 mm. Next, the DTG is
everted (<xref ref-type="fig" rid="f2">Figures 2B</xref> and <xref ref-type="fig" rid="f2">2C</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Step 2.</p></caption><graphic xlink:href="rbccv-34-05-0618-g02"/></fig>
</p></sec><sec><title>Step 3</title><p>Determine the size of the cusps by the following formula:</p><p>
<list list-type="simple"><list-item><p>a). If the size of DTG has an even value, then the size of the
neocusps equals DTG&#x02019;s size minus 1;</p></list-item><list-item><p>b). If the size of DTG has an odd value, then the size of the
neocusps equals DTG&#x02019;s size.</p></list-item></list>
</p><p>For example, with a DTG of size number 28, we apply the formula &#x02018;28 minus 1
equals 27&#x02019;. The neocusps&#x02019; size corresponds to the number 27 on Ozaki&#x02019;s
template.</p></sec><sec><title>Step 4</title><p>We cut out three identical cusps from the treated autologous pericardium (<xref ref-type="fig" rid="f3">Figures 3A</xref>, <xref ref-type="fig" rid="f3">3B</xref>, <xref ref-type="fig" rid="f3">3C</xref>, and <xref ref-type="fig" rid="f3">3D</xref>)</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Step 4.</p></caption><graphic xlink:href="rbccv-34-05-0618-g03"/></fig>
</p></sec><sec><title>Step 5</title><p>A 5-mm straight line is drawn from the lower edge of the DTG (5 mm will be needed
to fix the conduit to AVA). Further, we fix the cusps to the DTG with a
continuous suture line with prolene (<xref ref-type="fig" rid="f4">Figures
4A</xref>, <xref ref-type="fig" rid="f4">4B</xref>, and <xref ref-type="fig" rid="f4">4C</xref>).</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Step 5.</p></caption><graphic xlink:href="rbccv-34-05-0618-g04"/></fig>
</p></sec><sec><title>Step 6</title><p>After fixing the cusps, DTG is everted back to its original side (<xref ref-type="fig" rid="f5">Figures 5A</xref>, <xref ref-type="fig" rid="f5">5B</xref>, <xref ref-type="fig" rid="f5">5C</xref>, and <xref ref-type="fig" rid="f5">5D</xref>)</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Step 6.</p></caption><graphic xlink:href="rbccv-34-05-0618-g05"/></fig>
</p></sec><sec><title>Step 7</title><p>Cardiopulmonary bypass begins, cardioplegic solution is infused, and native AV
cusps are excised. The next step is the implantation of the resulting conduit
with fixation of the proximal end to AVA with horizontal mattress stitches.
Reimplantation of the coronary ostia is performed according to the standard
technique. The procedure ends with a distal anastomosis of DTG with AA (<xref ref-type="fig" rid="f6">Figures 6A</xref> and <xref ref-type="fig" rid="f6">6B</xref>).</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Step 7.</p></caption><graphic xlink:href="rbccv-34-05-0618-g06"/></fig>
</p></sec></sec><sec><title>TECHNIQUE NUMBER 2</title><p>This technique offers a more elaborate option to calculate the size of the DTG and
the size of the neocusps (according to <xref ref-type="fig" rid="f7">Figures
7</xref> and <xref ref-type="fig" rid="f8">8</xref>). The diameter of DTG is
also based on the previously measured AVA diameter, to which 5 mm is added.</p><p>
<fig id="f7" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Formulas to calculate the size of the Dacron tube graft (DTG) and of the
neocusps.</p></caption><graphic xlink:href="rbccv-34-05-0618-g07"/></fig>
</p><p>
<fig id="f8" orientation="portrait" position="float"><label>Fig. 8</label><caption><p>Formulas to calculate the size of the Dacron tube graft (DTG) and of the
neocusps.</p></caption><graphic xlink:href="rbccv-34-05-0618-g08"/></fig>
</p><p>Instead of everting DTG, this is cut along longitudinally, which results in a
rectangular section (<xref ref-type="fig" rid="f7">Figures 7A</xref> and <xref ref-type="fig" rid="f7">7B</xref>) with a width (w) equal to the length (L) of
the DTG circumference section, fixed at the angles to a flat surface. Along the left
and right edges, straight lines of 2.5-mm size are drawn (<xref ref-type="fig" rid="f7">Figure 7A</xref>) and these are needed for full restoration of the DTG
integrity later. Thus, the circumference of DTG (after the later restoration of its
integrity) will be L1, which equals to L minus 5 mm, and the diameter of DTG (D1)
equals to the formula in <xref ref-type="fig" rid="f7">Figures 7B</xref> and <xref ref-type="fig" rid="f8">8A</xref>.</p><p>The length of DTG is divided in three equal parts on the back side (<xref ref-type="fig" rid="f7">Figure 7A</xref>). Based on a formula (<xref ref-type="fig" rid="f8">Figure 8B</xref>) for the calculation of the
circumference around an equilateral triangle (<xref ref-type="fig" rid="f7">Figure
7B</xref>), we obtain the intercommissural distances (<xref ref-type="fig" rid="f7">Figures 7C</xref> and <xref ref-type="fig" rid="f8">8C</xref>) and the
size of the Ozaki&#x02019;s template is selected, with the help of which we cut out three
identical flaps from the treated autologous pericardium. At 5 mm from the bottom
edge of DTG, a straight line is drawn (5 mm will be needed to fix the conduit to the
aortic ring). A parallel straight line is also drawn at a distance from the first
straight line, equal to the height (h) of the commissures (<xref ref-type="fig" rid="f7">Figures 7A</xref> and <xref ref-type="fig" rid="f7">7C</xref>),
measured according to TEE. This line is then used for fixation of the neocusps to
DTG (<xref ref-type="fig" rid="f7">Figure 7C</xref>). Further, a continuous suture
line of prolene is used to fix the neocusps to the DTG (<xref ref-type="fig" rid="f9">Figure 9</xref>), which is wrapped around itself and restored (as a
tube) with a continuous suture line of prolene (<xref ref-type="fig" rid="f7">Figures 7D</xref> and <xref ref-type="fig" rid="f10">10</xref>). The next step
is the implantation of the resulting conduit with fixation of the proximal end to
AVA with horizontal mattress stitches (Central Figure). Reimplantation of the
coronary ostia is performed according to the standard technique. The procedure ends
with a distal anastomosis of DTG with AA.</p><p>
<fig id="f9" orientation="portrait" position="float"><label>Fig. 9</label><caption><p>Continuous suture line of prolene is used to fix the neocusps to the
Dacron tube graft (DTG).</p></caption><graphic xlink:href="rbccv-34-05-0618-g09"/></fig>
</p><p>
<fig id="f10" orientation="portrait" position="float"><label>Fig. 10</label><caption><p>The Dacron conduit is wrapped around itself and restored (as a tube) with
a continuous suture line of prolene.</p></caption><graphic xlink:href="rbccv-34-05-0618-g10"/></fig>
</p></sec><sec sec-type="conclusions"><title>COMMENTS</title><p>Most researchers believe that AV prostheses lead to improved longevity, reduce
complication rates, and improve quality of life<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>.
The preservation of residual obstruction of blood flow at the level of AV leads to a
slower decrease in left ventricular hypertrophy and progression of heart
failure<sup>[<xref rid="r9" ref-type="bibr">9</xref>-<xref rid="r12" ref-type="bibr">12</xref>]</sup>. The use of biological
materials for AVNeo is nothing new. Back in the 1960s, the first operations, in
which biological materials were used, were performed for AV-sparing procedure with
cusp elongation and even completely replacement of the AV cusp<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The idea of AVNeo using
autologous pericardium treated with glutaraldehyde was proposed in 1995 by Duran et
al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.
Gasparyan<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> proposed a formula to calculate the dimensions of the
cusps for AVNeo<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.
The Ozaki method showed promising mid-term results. After following 416 patients for
73 months, the reoperation-free survival rate was 96.7%<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. There is no doubt that
autologous pericardial neovalves have very low thrombogenicity and provide
hemodynamics similar to that in the native valve. Also important is the economic
aspect, since we can avoid the use of costly prostheses. Further studies are
warranted to determine the effectivity of the Russian conduit in the surgical
treatment of AV and AA pathologies.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">RK</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SE</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPBOS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DT</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Clinic of Aortic and Cardiovascular Surgery,
Sechenov First Moscow State Medical University of Health Ministry of Russia,
Moscow and the Department of Cardiac Surgery, Federal Center for Cardiovascular
Surgery, Astrakhan State Medical University, Astrakhan, Russia.</p></fn><fn fn-type="other"><p>Fast Track</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinov</surname><given-names>BA</given-names></name><name><surname>Belov Yu</surname><given-names>V</given-names></name><name><surname>Kuznechevsky</surname><given-names>FV</given-names></name></person-group><article-title>Aneurysms of the ascending aorta and arch of
aorta</article-title><source>M.: Astrel</source><year>2006</year><fpage>51</fpage><lpage>76</lpage><comment>Russian</comment></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Eusanio</surname><given-names>M</given-names></name><name><surname>Murana</surname><given-names>G</given-names></name><name><surname>Cefarelli</surname><given-names>M</given-names></name><name><surname>Mazzola</surname><given-names>A</given-names></name><name><surname>Di Bartolomeo</surname><given-names>R</given-names></name></person-group><article-title>The bentall procedure with a biological valved conduit:
substitute options and techniques</article-title><source>Multimed Man Cardiothorac Surg</source><year>2014</year><volume>2014</volume><!--<pub-id pub-id-type="pii">mmu010</pub-id>--><pub-id pub-id-type="doi">10.1093/mmcts/mmu010</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>RA</given-names></name><name><surname>Sadler</surname><given-names>L</given-names></name><name><surname>Stewart</surname><given-names>AW</given-names></name><name><surname>McCowan</surname><given-names>LM</given-names></name><name><surname>Kerr</surname><given-names>AR</given-names></name><name><surname>White</surname><given-names>HD</given-names></name></person-group><article-title>Long-term survival and valve-related complications in young women
with cardiac valve replacements</article-title><source>Circulation</source><year>1999</year><volume>99</volume><issue>20</issue><fpage>2669</fpage><lpage>2676</lpage><pub-id pub-id-type="doi">10.1161/01.cir.99.20.2669</pub-id><pub-id pub-id-type="pmid">10338461</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmunds</surname><given-names>LH Jr</given-names></name></person-group><article-title>Thrombotic and bleeding complications of prosthetic heart
valves</article-title><source>Ann Thorac Surg</source><year>1987</year><volume>44</volume><issue>4</issue><fpage>430</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/s0003-4975(10)63816-7</pub-id><pub-id pub-id-type="pmid">3310938</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SS</given-names></name><name><surname>Trento</surname><given-names>A</given-names></name><name><surname>DeRobertis</surname><given-names>M</given-names></name><name><surname>Kass</surname><given-names>RM</given-names></name><name><surname>Sandhu</surname><given-names>M</given-names></name><name><surname>Czer</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Twenty-year comparison of tissue and mechanical valve
replacement</article-title><source>J Thorac Cardiovasc Surg</source><year>2001</year><volume>122</volume><issue>2</issue><fpage>257</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1067/mtc.2001.115238</pub-id><pub-id pub-id-type="pmid">11479498</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahm</surname><given-names>M</given-names></name><name><surname>Husmann</surname><given-names>M</given-names></name><name><surname>Eckhard-Mayer</surname><given-names/></name><name><surname>Pr&#x000fc;fer</surname><given-names>D</given-names></name><name><surname>Groh</surname><given-names>E</given-names></name><name><surname>Oelert</surname><given-names>H</given-names></name></person-group><article-title>Relevance of immunologic reactions for tissue failure of
bioprosthetic heart valves</article-title><source>Ann Thorac Surg</source><year>1995</year><volume>60</volume><issue>2 Suppl</issue><fpage>S348</fpage><lpage>S352</lpage><pub-id pub-id-type="doi">10.1016/0003-4975(95)00291-r</pub-id><pub-id pub-id-type="pmid">7646186</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Human</surname><given-names>P</given-names></name><name><surname>Zilla</surname><given-names>P</given-names></name></person-group><article-title>Characterization of the immune response to valve bioprostheses
and its role in primary tissue failure</article-title><source>Ann Thorac Surg</source><year>2001</year><volume>71</volume><issue>5 Suppl</issue><fpage>S385</fpage><lpage>S388</lpage><pub-id pub-id-type="doi">10.1016/s0003-4975(01)02492-4</pub-id><pub-id pub-id-type="pmid">11388230</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>S</given-names></name><name><surname>Kawase</surname><given-names>I</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Nozawa</surname><given-names>Y</given-names></name><name><surname>Takatoh</surname><given-names>M</given-names></name></person-group><article-title>A total of 404 cases of aortic valve reconstruction with
glutaraldehyde-treated autologous pericardium</article-title><source>J Thorac Cardiovasc Surg</source><year>2014</year><volume>147</volume><issue>1</issue><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2012.11.012</pub-id><pub-id pub-id-type="pmid">23228404</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumesnil</surname><given-names>JG</given-names></name><name><surname>Pibarot</surname><given-names>P</given-names></name></person-group><article-title>Prosthesis-patient mismatch: an update</article-title><source>Curr Cardiol Rep</source><year>2011</year><volume>13</volume><issue>3</issue><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1007/s11886-011-0172-7</pub-id><pub-id pub-id-type="pmid">21350829</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huygens</surname><given-names>SA</given-names></name><name><surname>Mokhles</surname><given-names>MM</given-names></name><name><surname>Hanif</surname><given-names>M</given-names></name><name><surname>Bekkers</surname><given-names>JA</given-names></name><name><surname>Bogers</surname><given-names>AJ</given-names></name><name><surname>Rutten-van M&#x000f6;lken</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Contemporary outcomes after surgical aortic valve replacement
with bioprostheses and allografts: a systematic review and
meta-analysis</article-title><source>Eur J Cardiothorac Surg</source><year>2016</year><volume>50</volume><issue>4</issue><fpage>605</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezw101</pub-id><pub-id pub-id-type="pmid">27026750</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pibarot</surname><given-names>P</given-names></name><name><surname>Dumesnil</surname><given-names>JG</given-names></name></person-group><article-title>Prosthesis-patient mismatch: definition, clinical impact, and
prevention</article-title><source>Heart</source><year>2006</year><volume>92</volume><issue>8</issue><fpage>1022</fpage><lpage>1029</lpage><pub-id pub-id-type="doi">10.1136/hrt.2005.067363</pub-id><pub-id pub-id-type="pmid">16251232</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Vaquero</surname><given-names>D</given-names></name><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Diaz</surname><given-names>R</given-names></name><name><surname>Calvo</surname><given-names>D</given-names></name><name><surname>Khalpey</surname><given-names>Z</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>E</given-names></name><etal/></person-group><article-title>Moderate patient-prosthesis mismatch predicts cardiac events and
advanced functional class in young and middle aged patients undergoing
surgery due to severe aortic stenosis</article-title><source>J Card Surg</source><year>2014</year><volume>29</volume><issue>2</issue><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1111/jocs.12265</pub-id><pub-id pub-id-type="pmid">24330010</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duran</surname><given-names>CM</given-names></name><name><surname>Gometza</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Gallo</surname><given-names>R</given-names></name><name><surname>Martin-Duran</surname><given-names>R</given-names></name></person-group><article-title>Aortic valve replacement with freehand autologous
pericardium</article-title><source>J Thorac Cardiovasc Surg</source><year>1995</year><volume>110</volume><issue>2</issue><fpage>511</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(95)70248-2</pub-id><pub-id pub-id-type="pmid">7637369</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasparyan</surname><given-names>VC</given-names></name></person-group><article-title>Method of determination of aortic valve parameters for its
reconstruction with autopericardium: an experimental study</article-title><source>J Thorac Cardiovasc Surg</source><year>2000</year><volume>119</volume><issue>2</issue><fpage>386</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(00)70200-5</pub-id><pub-id pub-id-type="pmid">10649219</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>S</given-names></name><name><surname>Kawase</surname><given-names>I</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Takatoh</surname><given-names>M</given-names></name><name><surname>Hagiwara</surname><given-names>S</given-names></name><etal/></person-group><article-title>Aortic valve reconstruction using autologous pericardium for
aortic stenosis</article-title><source>Circ J</source><year>2015</year><volume>79</volume><issue>7</issue><fpage>1504</fpage><lpage>1510</lpage><pub-id pub-id-type="doi">10.1253/circj.CJ-14-1092</pub-id><pub-id pub-id-type="pmid">25818901</pub-id></element-citation></ref></ref-list></back></article>